Baltimore, MD12 Active Studies

Parkinsons Disease Clinical Trials in Baltimore, MD

Find 12 actively recruiting parkinsons disease clinical trials in Baltimore, MD. Connect with local research sites and explore new treatment options.

12
Active Trials
9
Sponsors
5,440
Enrolling

Recruiting Parkinsons Disease Studies in Baltimore

About Parkinsons Disease Clinical Trials in Baltimore

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 12 parkinsons disease clinical trials recruiting participants in Baltimore, MD. These studies are seeking a combined 5,440 participants. Research is being sponsored by Michael J. Fox Foundation for Parkinson's Research, University of Massachusetts, Worcester, JHSPH Center for Clinical Trials and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Baltimore — FAQ

Are there parkinsons disease clinical trials in Baltimore?

Yes, there are 12 parkinsons disease clinical trials currently recruiting in Baltimore, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Baltimore?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.

Are clinical trials in Baltimore free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 12 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 18, 2026 from ClinicalTrials.gov